- Home
- LGVN vs PRPH Comparison
LGVN vs PRPH Comparison
Compare LGVN & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- PRPH
- Stock Information
- Founded
- LGVN 2014
- PRPH 1989
- Country
- LGVN United States
- PRPH United States
- Employees
- LGVN N/A
- PRPH N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- LGVN Health Care
- PRPH Health Care
- Exchange
- LGVN Nasdaq
- PRPH Nasdaq
- Market Cap
- LGVN 16.4M
- PRPH 17.9M
- IPO Year
- LGVN 2021
- PRPH 1997
- Fundamental
- Price
- LGVN $0.77
- PRPH $0.42
- Analyst Decision
- LGVN Strong Buy
- PRPH
- Analyst Count
- LGVN 2
- PRPH 0
- Target Price
- LGVN $6.50
- PRPH N/A
- AVG Volume (30 Days)
- LGVN 410.9K
- PRPH 2.5M
- Earning Date
- LGVN 11-11-2025
- PRPH 11-12-2025
- Dividend Yield
- LGVN N/A
- PRPH N/A
- EPS Growth
- LGVN N/A
- PRPH N/A
- EPS
- LGVN N/A
- PRPH N/A
- Revenue
- LGVN $2,073,000.00
- PRPH $5,588,000.00
- Revenue This Year
- LGVN N/A
- PRPH $221.82
- Revenue Next Year
- LGVN N/A
- PRPH N/A
- P/E Ratio
- LGVN N/A
- PRPH N/A
- Revenue Growth
- LGVN 68.67
- PRPH N/A
- 52 Week Low
- LGVN $0.63
- PRPH $0.22
- 52 Week High
- LGVN $2.48
- PRPH $2.69
- Technical
- Relative Strength Index (RSI)
- LGVN 38.17
- PRPH 53.79
- Support Level
- LGVN $0.74
- PRPH $0.34
- Resistance Level
- LGVN $0.85
- PRPH $0.45
- Average True Range (ATR)
- LGVN 0.05
- PRPH 0.06
- MACD
- LGVN 0.02
- PRPH 0.00
- Stochastic Oscillator
- LGVN 34.25
- PRPH 36.54
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.